These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 6196037)
1. Activation of calcium channels by novel 1,4-dihydropyridines. A new mechanism for positive inotropics or smooth muscle stimulants. Schramm M; Thomas G; Towart R; Franckowiak G Arzneimittelforschung; 1983; 33(9):1268-72. PubMed ID: 6196037 [TBL] [Abstract][Full Text] [Related]
2. Calcium agonism, a new mechanism for positive inotropy. Hemodynamic effects and mode of action of BAY K 8644. Schramm M; Towart R; Kazda S; Thomas G; Franckowiak G Adv Myocardiol; 1985; 6():59-70. PubMed ID: 2581301 [TBL] [Abstract][Full Text] [Related]
3. Vascular and cardiac effects of a new dihydropyridine derivative, YC-170: a comparison with Bay K 8644. Hattori Y; Nakaya H; Tohse N; Kanno M J Pharmacol Exp Ther; 1986 Aug; 238(2):670-8. PubMed ID: 2426442 [TBL] [Abstract][Full Text] [Related]
4. Calcium channel modulation: ability to inhibit or promote calcium influx resides in the same dihydropyridine molecule. Thomas G; Gross R; Schramm M J Cardiovasc Pharmacol; 1984; 6(6):1170-6. PubMed ID: 6084776 [TBL] [Abstract][Full Text] [Related]
5. [Effects of a new 1,4-dihydropyridine, Bay K 8644, on smooth muscle organs isolated from the guinea pig]. Lograno M; De Luca A; Persichella M; Conte-Camerino D Boll Soc Ital Biol Sper; 1986 Apr; 62(4):471-8. PubMed ID: 2427095 [No Abstract] [Full Text] [Related]
6. Agonist actions of Bay K 8644, a dihydropyridine derivative, on the voltage-dependent calcium influx in smooth muscle cells of the rabbit mesenteric artery. Kanmura Y; Itoh T; Kuriyama H J Pharmacol Exp Ther; 1984 Dec; 231(3):717-23. PubMed ID: 6209390 [TBL] [Abstract][Full Text] [Related]
7. Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels. Schramm M; Thomas G; Towart R; Franckowiak G Nature; 1983 Jun 9-15; 303(5917):535-7. PubMed ID: 6190088 [TBL] [Abstract][Full Text] [Related]
8. Effects of Bay k 8644 and nifedipine on isolated dog cerebral, coronary and mesenteric arteries. Asano M; Aoki K; Suzuki Y; Matsuda T J Pharmacol Exp Ther; 1987 Nov; 243(2):646-56. PubMed ID: 2445956 [TBL] [Abstract][Full Text] [Related]
9. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies. Polster P; Christophe B; Van Damme M; Houlliche A; Chatelain P J Pharmacol Exp Ther; 1990 Nov; 255(2):593-9. PubMed ID: 1700816 [TBL] [Abstract][Full Text] [Related]
10. Activation of Ca channels in heart muscle by a new dihydropyridine derivative. Nilius B Gen Physiol Biophys; 1984 Oct; 3(5):437-40. PubMed ID: 6210228 [No Abstract] [Full Text] [Related]
11. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries. Kanda M; Shirahase H; Kurahashi K; Wada K; Nakamura S; Matsui H; Fukata F Arzneimittelforschung; 1995 Aug; 45(8):831-5. PubMed ID: 7575741 [TBL] [Abstract][Full Text] [Related]
12. Stimulation of Ca-dependent action potentials in mammalian ventricular myocardium by a novel dihydropyridine. Nilius B Biomed Biochim Acta; 1984; 43(12):1385-97. PubMed ID: 6085472 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of the calcium-agonistic dihydropyridine BAY K 8644 in conscious dogs. Gross R; Kayser M; Schramm M; Taniel R; Thomas G Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):203-16. PubMed ID: 2415078 [TBL] [Abstract][Full Text] [Related]
14. The optical isomers of the 1,4-dihydropyridine BAY K 8644 show opposite effects on Ca channels. Franckowiak G; Bechem M; Schramm M; Thomas G Eur J Pharmacol; 1985 Aug; 114(2):223-6. PubMed ID: 2412855 [TBL] [Abstract][Full Text] [Related]
15. Interactions between a "calcium channel agonist", Bay K 8644, and calcium antagonists differentiate calcium antagonist subgroups in K+-depolarized smooth muscle. Spedding M; Berg C Naunyn Schmiedebergs Arch Pharmacol; 1984 Nov; 328(1):69-75. PubMed ID: 6083458 [TBL] [Abstract][Full Text] [Related]
16. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate. Yamaura T; Kase N; Kita H; Uematsu T Arzneimittelforschung; 1986; 36(1):29-34. PubMed ID: 3754142 [TBL] [Abstract][Full Text] [Related]
17. Voltage-dependent effects of YC-170, a dihydropyridine calcium channel modulator, in cardiovascular tissues. Nakaya H; Hattori Y; Tohse N; Kanno M Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):421-30. PubMed ID: 2430192 [TBL] [Abstract][Full Text] [Related]
19. Is antagonism by Bay k 8644 of the negative dromotropic effect of nifedipine pharmacological? Taira N; Wada Y; Satoh K J Pharmacol Exp Ther; 1985 Jan; 232(1):244-50. PubMed ID: 2578189 [TBL] [Abstract][Full Text] [Related]
20. Modulation of calcium ion influx by the 1,4-dihydropyridines nifedipine and BAY K 8644. Schramm M; Towart R; Lamp B; Thomas G J Cardiovasc Pharmacol; 1985; 7(3):493-6. PubMed ID: 2410679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]